IMNM
IMNM
NASDAQ · Biotechnology

Immunome Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$20.30
+0.09 (+0.45%)
As of Mar 25, 8:55 PM ET ·
Analyst Consensus
Strong Buy
20
Analysts
High
Coverage
Buy 19 95%
Hold 1 5%
Sell 0 0%
Price Target
Analyst Price Target +547.7% upside
Low Target $82.08
Average Target $131.49
High Target $141.61
Current Price $20.30
Current
$20.30
Target
$131.49
$82.08 $131.49 avg $141.61
Scenario Analysis
Bear Case
$82.08
304.3%
Low target
Base Case
$131.49
+547.7%
Avg target
Bull Case
$141.61
+597.6%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$27.65
-26.6% from high
52-Week Low
$5.15
+294.2% from low
50-Day SMA
$22.49
-9.7% vs SMA
200-Day SMA
$14.32
+41.8% vs SMA
RSI (14)
37.4
Neutral
Target vs 52W High
$131.49
+375.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Buy 39 69% $257.58 +24.3%
AMGN
Amgen Inc
 Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +162.3%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 -3.7%
REGN
Regeneron Pharmaceuticals
 Strong Buy 36 75% $76.80 -89.8%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
 Strong Buy 26 92% $143.40 -3.3%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -27.6%